 Receptor guanylate cyclase C (GC-C) is a type I transmembrane glycoprotein expressed on intestinal brush border membranes of intestinal epithelial cells and transformed human colon cancer cell lines (e.g., T84) (1). GC-C is expressed in very low levels on the other tissues and is highly expressed on the primary and metastatic colon cancer tissues (2). Peptides such as the 